Intraoperative Pancreatic Ductoscopy for Ampullary Adenocarcinoma During Pancreatic Resection: A Case Report [0.03%]
胰腺切除术中胆管癌乳头状腺癌的术中胰管内窥镜检查：病例报告
Anthony Congiusta,Ariel Brown,Andrew M Brown et al.
Anthony Congiusta et al.
Background: Periampullary neoplasms can be challenging to work up and diagnose preoperatively. Herein, we report the case of a patient whose preoperative workup failed to detect a malignancy, yet, underwent a pylorus-preserving pancreaticod...
Parenchyma Preserving Surgery for Idiopathic Chronic Calcific Pancreatitis in Children: A Report of Three Cases [0.03%]
儿童自身免疫性慢性钙化性胰腺炎的胰腺实质保留手术治疗：3例报告
Tewodross Getu Wolde,Baobao Cai,Guo Feng et al.
Tewodross Getu Wolde et al.
Background: Idiopathic chronic calcific pancreatitis is a rare entity. Early surgical intervention and a parenchyma sparing procedure should be advocated to prevent further decay of the pancreas and the occurrence of cancer. Case Presentati...
Portal-Mesenteric Vein Resection in Borderline Pancreatic Cancer; 33 Month-Survival in Patients with Good Performance Status [0.03%]
良好体能状态的边缘性胰腺癌患者的 portal-mesenteric vein 切除术——长达 33 个月的患者生存期
Gregory G Tsiotos,Nikiforos Ballian,Theodoros Michelakos et al.
Gregory G Tsiotos et al.
Background: Patients with pancreatic cancer (PC), which is not upfront resectable, but borderline, involving major peripancreatic vessels, have not been generally considered for surgery, considering that resection in such a setting may be f...
A Phase I/II Open-Label Multicenter Single-Arm Study of FABLOx (Metronomic 5-Fluorouracil Plus nab-Paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin) in Patients with Metastatic Pancreatic Cancer [0.03%]
关于FABLOx（来那替尼，纳曲泊帕，贝伐单抗，亚叶酸和氧化奥沙利铂）治疗转移性胰腺癌患者I/II期开放多中心单臂研究
Vaibhav Sahai,M Wasif Saif,Aparna Kalyan et al.
Vaibhav Sahai et al.
Purpose: To evaluate safety and preliminary efficacy of metronomic 5-fluorouracil plus nab-paclitaxel, bevacizumab, leucovorin, and oxaliplatin (FABLOx) in patients with newly diagnosed metastatic pancreatic cancer (MPC). Methods: A total o...
Charles J Yeo
Charles J Yeo
Wissam Hanayneh,Hiral Parekh,Garrett Fitzpatrick et al.
Wissam Hanayneh et al.
Background: Pancreatic adenocarcinoma remains one of the most lethal malignancies with little treatment advancements. Other less common pancreatic cancer histologies have different outcomes and disease course. In this article, we report two...
Multifocal High-Grade Pancreatic Precursor Lesions: A Case Series and Management Recommendations [0.03%]
多发高级别胰腺癌前病变的病例系列和管理建议
Mazhar Soufi,Michele T Yip-Schneider,Rosalie A Carr et al.
Mazhar Soufi et al.
Background: The risk of developing invasive cancer in the remnant pancreas after resection of multifocal high-grade pancreatic precursor lesions is not well known. We report three patients who were followed up after resection of multifocal ...
Adrenocorticotropin Hormone Secreting Carcinoma of the Pancreas: A Case Report [0.03%]
分泌促肾上腺皮质激素的胰腺癌一例报告
Josh Bleicher,Sarah Lombardo,Stacie Carbine et al.
Josh Bleicher et al.
Introduction: Adrenocorticotropin hormone (ACTH) secreting pancreatic neuroendocrine neoplasms (pNENs) are rare. The clinical and biological behavior of pNENs is poorly understood. Patients often present at an advanced stage of disease and ...
A Pilot Trial of Molecularly Tailored Therapy for Patients with Metastatic Pancreatic Ductal Adenocarcinoma [0.03%]
转移性胰腺导管腺癌分子靶向治疗的试点研究
Anteneh A Tesfaye,Hongkun Wang,Marion L Hartley et al.
Anteneh A Tesfaye et al.
Purpose: Despite the wide adoption of tumor molecular profiling, there is a dearth of evidence linking molecular biomarkers for treatment selection to prediction of treatment outcomes in patients with metastatic pancreatic cancer. We initia...
Genetic Drivers of Pancreatic Cancer Are Identical Between the Primary Tumor and a Secondary Lesion in a Long-Term (>5 Years) Survivor After a Whipple Procedure [0.03%]
胰腺癌遗传驱动因素在 whipple 手术五年以上的生存者的主要肿瘤和继发病灶中相同
Tyler M Bauer,Teena Dhir,Adam Strickland et al.
Tyler M Bauer et al.
Background: A new mass in the remnant pancreas of a patient with previously resected pancreatic ductal adenocarcinoma (PDA) typically represents either a recurrence of the initial primary tumor or a second primary tumor. Recent advances in ...